| Website | allocure.com |
| Category | BioTech |
| Phone | 801-583-8450 |
| allocure@allocure... | |
| Employees | |
| Founded | 2008 |
| TOTAL | $25M |
| FUNDING TOTAL | $25M |
| Series B, 4/12 Lundbeckfrond Ventures SV Life Sciences Novo A/S | $25M |
| DEBT TOTAL | $1.5M |
| Debt, 10/11 | $1.5M |
AlloCure, Inc., a biotechnology company, develops cell therapies for the treatment of various kidney diseases, organ transplants, and multi-organ injuries. It offers biological therapeutics for acute kidney injuries. AlloCure is based in Burlington, Massachusetts. It has operations in Salt Lake City, Utah and Hamburg, Germany. AlloCure is dedicated to the development of off-the-shelf biological therapies to treat serious and debilitating diseases that afflict millions of people around the world. AlloCure’s unique technology uses processed cells derived from human bone marrow to treat a wide variety of diseases. AlloCure was founded on the unique and proprietary technology developed by Dr. Christof Westenfelder and Dr. Axel Zander. Westenfelder and Zander are world renowned scientists who have dedicated their careers to developing effective therapies for kidney disease. AlloCure has operations in Salt lake City Utah and Hamburg Germany.
